O6-Methylguanine-DNA Methytransferase (MGMT) Immunohistochemistry as a Predictor of Resistance to Temozolomide in Primary CNS Lymphoma

被引:0
|
作者
Jiang, X.
Reardon, D. A.
Desjardins, A.
Vredenburgh, J. J.
Quinn, J. A.
Austin, A. D.
Herndon, J. E.
McLendon, R. E.
Friedman, H. S.
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1620
引用
收藏
页码:382A / 382A
页数:1
相关论文
共 50 条
  • [1] O6-Methylguanine-DNA Methytransferase (MGMT) Immunohistochemistry as a Predictor of Resistance to Temozolomide in Primary CNS Lymphoma.
    Jiang, X.
    Reardon, D. A.
    Desjardins, A.
    Vredenburgh, J. J.
    Quinn, J. A.
    Austin, A. D.
    Herndon, J. E.
    McLendon, R. E.
    Friedman, H. S.
    MODERN PATHOLOGY, 2011, 24 : 382A - 382A
  • [2] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Xiaoyin Jiang
    David A. Reardon
    Annick Desjardins
    James J. Vredenburgh
    Jennifer A. Quinn
    Alan D. Austin
    James E. Herndon
    Roger E. McLendon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2013, 114 : 135 - 140
  • [3] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Jiang, Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Quinn, Jennifer A.
    Austin, Alan D.
    Herndon, James E., II
    McLendon, Roger E.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 135 - 140
  • [4] O6-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives
    Okamoto, R
    Takano, H
    Okamura, T
    Park, JS
    Tanimoto, K
    Sekikawa, T
    Yamamoto, W
    Sparreboom, A
    Verweij, J
    Nishiyama, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (01): : 93 - 102
  • [5] Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O6-methylguanine-DNA methyltransferase (MGMT) expression
    Zhu, Zhongling
    Du, Shuangshuang
    Ding, Fengxia
    Guo, Shanshan
    Ying, Guoguang
    Yan, Zhao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 3299 - 3308
  • [6] Progression of O6-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research
    Jiang, Guan
    Jiang, Ai-Jun
    Xin, Yong
    Li, Lian-Tao
    Cheng, Qian
    Zheng, Jun-Nian
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (10) : 6659 - 6665
  • [7] Progression of O6-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research
    Guan Jiang
    Ai-Jun Jiang
    Yong Xin
    Lian-Tao Li
    Qian Cheng
    Jun-Nian Zheng
    Molecular Biology Reports, 2014, 41 : 6659 - 6665
  • [8] Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
    McCormack, Ann I.
    McDonald, Kerrie L.
    Gill, Anthony J.
    Clark, Susan J.
    Burt, Morton G.
    Campbell, Kirsten A.
    Braund, Wilton J.
    Little, Nicholas S.
    Cook, Raymond J.
    Grossman, Ashley B.
    Robinson, Bruce G.
    Clifton-Bligh, Roderick J.
    CLINICAL ENDOCRINOLOGY, 2009, 71 (02) : 226 - 233
  • [9] O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
    Middleton, MR
    Lunn, JM
    Morris, C
    Rustin, G
    Wedge, SR
    Brampton, MH
    Lind, MJ
    Lee, SM
    Newell, DR
    Bleehen, NM
    Newlands, ES
    Calvert, AH
    Margison, GP
    Thatcher, N
    BRITISH JOURNAL OF CANCER, 1998, 78 (09) : 1199 - 1202
  • [10] O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
    MR Middleton
    JM Lunn
    C Morris
    G Rustin
    SR Wedge
    MH Brampton
    MJ Lind
    SM Lee
    DR Newell
    NM Bleehen
    ES Newlands
    AH Calvert
    GP Margison
    N Thatcher
    British Journal of Cancer, 1998, 78 : 1199 - 1202